The global thyroid cancer drugs market was valued at US$ 412 million in 2021 and is predicted to reach US$ 1,752 million by 2030; which is expected to experience a compound annual growth rate (CAGR) of 17.6% during the forecast period from 2022- 2030. Thyroid cancer is termed as a cancer which is developed in the cells of thyroid gland. It doesn’t show initially but grows severe and starts paining with swelling in the neck region. It shows lump in the most of the thyroid cancers can be treated with treatment. Treatments available for thyroid cancer includes radioactive ablation, thyroid stimulating hormone (TSH) suppression therapy, and removal of thyroid gland.
Request To Download Sample of This Strategic Report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
Market Dynamics
Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected with thyroid cancer during their lifespan. According to American Cancer Society, around 52,070 cases of the thyroid have been found in 2019 in US and estimated death recorded is 2170. Additionally, increasing awareness of thyroid cancer is assisting the growth of the market. Government has been raising funds and reimbursement policies are the factors propelling the growth of global thyroid cancer drugs market. According to Cancer Research UK in 2015, there were 3528 new cases of thyroid cancer registered in 2015. However, there are some restraints leading to the growth of the global thyroid cancer drugs market. Incompetence of drugs in providing effective output to thyroid cancer patients is expected as a major challenge for the growth of the global thyroid cancer drugs market. Additionally, patent expiry of patented drugs along with introduction of new generic version of drugs is obstructing growth of global thyroid cancer drugs market.
Global thyroid cancer drugs market is segmented on the basis of treatment, type, end- user, drug type, route of administration and region. Based on type, it is bifurcated into thyroid cancer, hurthle cell cancer, follicular thyroid cancer, anaplastic thyroid cancer and medullary thyroid cancer (MTC). By treatment, it is categorized into medication, radioactive iodine (radioiodine) therapy, hormone therapy, chemotherapy, and surgery. Surgery is further segmented into near-total thyroidectomy, total thyroidectomy and lobectomy. Further based on drug type, thyroid cancer drugs are Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Cometriq (Cabozantinib-S-Malate), Lenvatinib Mesylate, Nivolumab, Vandetanib and others. By route of administration, it is categorized into injectable, oral and others. On the basis of end- user, it is categorised into oncology clinics, hospitals, research organisations and others. Based on regional prospects, it is classified into North America (Canada, US and Rest of North America), Asia Pacific (China, South Korea, Japan, Rest of Asia Pacific), Europe (Germany, UK, France, Rest of Europe), Rest of the World (Middle East & Africa, Latina America).
Major players covered in the global thyroid cancer drug market report are Mylan N.V., Abbott, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, AstraZeneca, GlaxoSmithKline plc, Eisai Co., Ltd, Takeda Pharmaceutical Company Ltd, Biovista, Cytori Therapeutics Inc, Bayer AG, Novartis AG, Jerome Stevens Pharmaceuticals Inc, Baxter, Celgene Corporation, Bio-Path Holdings, Inc. and Vascular Biogenics, among others.
Download Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report ) @https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
Segmentation and Scope of the Global Thyroid Cancer Drugs Market
Global Thyroid Cancer Drugs Market is segmented into treatment, type, end- user, drug type, route of administration and region.
By Type
Thyroid cancer
Hurthle cell cancer
Follicular thyroid cancer
Anaplastic thyroid cancer
Medullary thyroid cancer (MTC)
By Treatment
Medication
Radioactive iodine (radioiodine) therapy
Hormone therapy
Chemotherapy
Surgery
Near-total thyroidectomy
Total thyroidectomy and lobectomy
By Drug Type
Ipilimumab
Cabozantinib-S-Malate
Caprelsa (Vandetanib)
Doxorubicin Hydrochloride
Cometriq (Cabozantinib-S-Malate)
Lenvatinib Mesylate
Nivolumab
Vandetanib
Others
By End Users:
Hospitals
Oncology Clinics
Research Organizations
Others
By route of administration
Injectable
Oral
Others
Get The Insights You Need By Customizing Your Report To Fit Your Unique Needs And Goals:https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
By Geography:
North America
US
Canada
Rest of North America
Europe
UK
Germany
Europe
Italy
Rest of Europe
Asia Pacific
Japan
China
South Korea
Rest of Asia Pacific
Rest of World
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Rest of Latin America
Prominent players in the Global Thyroid Cancer Drugs Market among others include
Mylan N.V.
Abbott
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd
AstraZeneca
GlaxoSmithKline plc
Eisai Co. Ltd
Takeda Pharmaceutical Company Ltd
Biovista
Cytori Therapeutics Inc
Bayer AG
Novartis AG
Jerome Stevens Pharmaceuticals Inc
Baxter
Celgene Corporation
Bio-Path Holdings Inc.
Vascular Biogenics
Get a Sample PDF copy of the report @https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
Table of Content
Chapter 1: Global Thyroid Cancer Drugs Industry Overview
Chapter 3: Market Dynamics
Chapter 4: Top Company Profiles
Chapter 5: Global Thyroid Cancer Drugs market Competition, by Players
Chapter 6: Global Market Size by Regions
Chapter 7: Global Market Segment by Application
Chapter 8: Global Thyroid Cancer Drugs Industry Segment by Type
Chapter 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Chapter 10: Strategies and key policies by Distributors/Suppliers/Traders
Chapter 11: Key Marketing Strategy Analysis, by Market Vendors
Chapter 12: Market Effect Factors Analysis
Chapter 13: Global Thyroid Cancer Drugs market Size Forecast (2023-2031).
Continue….
Reasons to Buy This Report
(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.
(B) The report offers comprehensive analysis of Thyroid Cancer Drugs market revenues on a global, regional, and country level, projecting trends until 2031. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.
(C) The research includes segmentation of the Thyroid Cancer Drugs market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.
(D) Analysis of the Thyroid Cancer Drugs market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.
(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.
(F) The study helps evaluate Thyroid Cancer Drugs business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.
Access Full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=Pol524
About Report Ocean:
Report Ocean is a renowned provider of market research reports, offering high-quality insights to clients in various industries. Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing their market share in today’s competitive environment. As a trusted source for innovative market research reports, Report Ocean serves as a comprehensive solution for individuals, organizations, and industries seeking valuable market intelligence.
Contact Information:
Email:[email protected]
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, United States
Telephone: +1 888 212 3539 (US – Toll-Free)
For more information and to explore their offerings, visit their website at:https://www.reportocean.com/